Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Hepatology. 2016 Mar 15;63(6):1860–1874. doi: 10.1002/hep.28472

Figure 1. Hepatic CES2 expression is down-regulated in db/db mice, HFD-fed mice and NASH patients.

Figure 1

(A) Hepatic mRNA level in db/db mice (n=4). Pgc1α serves as a positive control. (B) Hepatic protein levels in db/db mice (left panel) and relative CES2 protein level (right panel) (n=4). (C) Hepatic mRNA levels in HFD-fed mice (n=6–9). Cd36 serves as a positive control. (D) Hepatic protein levels in HFD-fed mice (left panel) and relative CES2 protein level (right panel) (n=6–9). (E) Hepatic protein level in NASH patients (left panel) and relative CES2 protein level (right panel) (n=8). *P<0.05, **P<0.01